+1 347 708 0418
The Next Generation Diabetes Therapy and Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Next Generation Diabetes Therapy and Drug Delivery size is estimated to be USD 4046.2 million in 2026 from USD 1808.7 million in 2020, with a change XX% between 2020 and 2021. The global Next Generation Diabetes Therapy and Drug Delivery market size is expected to grow at a CAGR of 22.3% for the next five years.
Market segmentation
Next Generation Diabetes Therapy and Drug Delivery market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
Market segment by Application, can be divided into
Diagnostic/Clinics
ICUs
Home Healthcare
Market segment by players, this report covers
Johnson & Johnson
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind Corporation
Enteris BioPharma
Dexcom
Senseonics
Medtech
Synertech
Zosano Pharma
Relmada Therapeutics
Eli Lilly and Company
Transdermal Specialties
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Next Generation Diabetes Therapy and Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Next Generation Diabetes Therapy and Drug Delivery, with revenue, gross margin and global market share of Next Generation Diabetes Therapy and Drug Delivery from 2019 to 2021.
Chapter 3, the Next Generation Diabetes Therapy and Drug Delivery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Next Generation Diabetes Therapy and Drug Delivery market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Next Generation Diabetes Therapy and Drug Delivery research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Next Generation Diabetes Therapy and Drug Delivery
1.2 Classification of Next Generation Diabetes Therapy and Drug Delivery by Type
1.2.1 Overview: Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type in 2020
1.2.3 Inhalable Insulin
1.2.4 Oral Insulin
1.2.5 Insulin Patches
1.2.6 CGM Systems
1.2.7 Artificial Pancreas
1.3 Global Next Generation Diabetes Therapy and Drug Delivery Market by Application
1.3.1 Overview: Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Global Next Generation Diabetes Therapy and Drug Delivery Market Size & Forecast
1.5 Global Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast by Region
1.5.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region, (2016-2021)
1.5.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.5.4 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.5.6 South America Next Generation Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Next Generation Diabetes Therapy and Drug Delivery Market Drivers
1.6.2 Next Generation Diabetes Therapy and Drug Delivery Market Restraints
1.6.3 Next Generation Diabetes Therapy and Drug Delivery Trends Analysis
2 Company Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
2.1.4 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Johnson & Johnson Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
2.2.4 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
2.3.4 Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Medtronic Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
2.4.4 Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 Novo Nordisk
2.5.1 Novo Nordisk Details
2.5.2 Novo Nordisk Major Business
2.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
2.5.4 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Novo Nordisk Recent Developments and Future Plans
2.6 MannKind Corporation
2.6.1 MannKind Corporation Details
2.6.2 MannKind Corporation Major Business
2.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
2.6.4 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 MannKind Corporation Recent Developments and Future Plans
2.7 Enteris BioPharma
2.7.1 Enteris BioPharma Details
2.7.2 Enteris BioPharma Major Business
2.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
2.7.4 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Enteris BioPharma Recent Developments and Future Plans
2.8 Dexcom
2.8.1 Dexcom Details
2.8.2 Dexcom Major Business
2.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
2.8.4 Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Dexcom Recent Developments and Future Plans
2.9 Senseonics
2.9.1 Senseonics Details
2.9.2 Senseonics Major Business
2.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
2.9.4 Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Senseonics Recent Developments and Future Plans
2.10 Medtech
2.10.1 Medtech Details
2.10.2 Medtech Major Business
2.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
2.10.4 Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Medtech Recent Developments and Future Plans
2.11 Synertech
2.11.1 Synertech Details
2.11.2 Synertech Major Business
2.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
2.11.4 Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Synertech Recent Developments and Future Plans
2.12 Zosano Pharma
2.12.1 Zosano Pharma Details
2.12.2 Zosano Pharma Major Business
2.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
2.12.4 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Zosano Pharma Recent Developments and Future Plans
2.13 Relmada Therapeutics
2.13.1 Relmada Therapeutics Details
2.13.2 Relmada Therapeutics Major Business
2.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
2.13.4 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Relmada Therapeutics Recent Developments and Future Plans
2.14 Eli Lilly and Company
2.14.1 Eli Lilly and Company Details
2.14.2 Eli Lilly and Company Major Business
2.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
2.14.4 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Eli Lilly and Company Recent Developments and Future Plans
2.15 Transdermal Specialties
2.15.1 Transdermal Specialties Details
2.15.2 Transdermal Specialties Major Business
2.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
2.15.4 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Transdermal Specialties Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Next Generation Diabetes Therapy and Drug Delivery Players Market Share
3.2.2 Top 10 Next Generation Diabetes Therapy and Drug Delivery Players Market Share
3.2.3 Market Competition Trend
3.3 Next Generation Diabetes Therapy and Drug Delivery Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue and Market Share by Type (2016-2021)
4.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2016-2021)
5.2 Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
6.2 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
6.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country
6.3.1 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)
6.3.2 United States Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
6.3.3 Canada Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
6.3.4 Mexico Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
7.2 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
7.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country
7.3.1 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)
7.3.2 Germany Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7.3.3 France Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7.3.5 Russia Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7.3.6 Italy Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
8.2 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
8.3 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region
8.3.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Region (2016-2026)
8.3.2 China Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.3 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.4 South Korea Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.5 India Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.7 Australia Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
9.2 South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
9.3 South America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country
9.3.1 South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)
9.3.2 Brazil Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
9.3.3 Argentina Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
10.2 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
10.3 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country
10.3.1 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)
10.3.2 Turkey Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
10.3.4 UAE Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million) by Region (2016-2021)
Table 5. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Region (2021-2026)
Table 6. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 7. Johnson & Johnson Major Business
Table 8. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
Table 9. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
Table 13. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Medtronic Corporate Information, Head Office, and Major Competitors
Table 15. Medtronic Major Business
Table 16. Medtronic Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
Table 17. Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Sanofi Corporate Information, Head Office, and Major Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
Table 21. Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 23. Novo Nordisk Major Business
Table 24. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
Table 25. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. MannKind Corporation Corporate Information, Head Office, and Major Competitors
Table 27. MannKind Corporation Major Business
Table 28. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
Table 29. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Enteris BioPharma Corporate Information, Head Office, and Major Competitors
Table 31. Enteris BioPharma Major Business
Table 32. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
Table 33. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Dexcom Corporate Information, Head Office, and Major Competitors
Table 35. Dexcom Major Business
Table 36. Dexcom Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
Table 37. Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Senseonics Corporate Information, Head Office, and Major Competitors
Table 39. Senseonics Major Business
Table 40. Senseonics Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
Table 41. Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Medtech Corporate Information, Head Office, and Major Competitors
Table 43. Medtech Major Business
Table 44. Medtech Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
Table 45. Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Synertech Corporate Information, Head Office, and Major Competitors
Table 47. Synertech Major Business
Table 48. Synertech Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
Table 49. Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Zosano Pharma Corporate Information, Head Office, and Major Competitors
Table 51. Zosano Pharma Major Business
Table 52. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
Table 53. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Relmada Therapeutics Corporate Information, Head Office, and Major Competitors
Table 55. Relmada Therapeutics Major Business
Table 56. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
Table 57. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors
Table 59. Eli Lilly and Company Major Business
Table 60. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
Table 61. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Transdermal Specialties Corporate Information, Head Office, and Major Competitors
Table 63. Transdermal Specialties Major Business
Table 64. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product and Solutions
Table 65. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million) by Players (2019-2021)
Table 67. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Players (2019-2021)
Table 68. Breakdown of Next Generation Diabetes Therapy and Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Next Generation Diabetes Therapy and Drug Delivery Players Head Office, Products and Services Provided
Table 70. Next Generation Diabetes Therapy and Drug Delivery Mergers & Acquisitions in the Past Five Years
Table 71. Next Generation Diabetes Therapy and Drug Delivery New Entrants and Expansion Plans
Table 72. Global Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million) by Type (2016-2021)
Table 73. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Type (2016-2021)
Table 74. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Forecast by Type (2021-2026)
Table 75. Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021)
Table 76. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Forecast by Application (2021-2026)
Table 77. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 78. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 79. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 80. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 81. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 82. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Region (2021-2026) & (USD Million)
Table 95. South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 96. South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 97. South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 98. South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 99. South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 100. South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Next Generation Diabetes Therapy and Drug Delivery Picture
Figure 2. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type in 2020
Figure 3. Inhalable Insulin
Figure 4. Oral Insulin
Figure 5. Insulin Patches
Figure 6. CGM Systems
Figure 7. Artificial Pancreas
Figure 8. Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application in 2020
Figure 9. Diagnostic/Clinics Picture
Figure 10. ICUs Picture
Figure 11. Home Healthcare Picture
Figure 12. Global Next Generation Diabetes Therapy and Drug Delivery Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Next Generation Diabetes Therapy and Drug Delivery Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Region (2016-2026)
Figure 15. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Region in 2020
Figure 16. North America Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Next Generation Diabetes Therapy and Drug Delivery Market Drivers
Figure 22. Next Generation Diabetes Therapy and Drug Delivery Market Restraints
Figure 23. Next Generation Diabetes Therapy and Drug Delivery Market Trends
Figure 24. Johnson & Johnson Recent Developments and Future Plans
Figure 25. Abbott Laboratories Recent Developments and Future Plans
Figure 26. Medtronic Recent Developments and Future Plans
Figure 27. Sanofi Recent Developments and Future Plans
Figure 28. Novo Nordisk Recent Developments and Future Plans
Figure 29. MannKind Corporation Recent Developments and Future Plans
Figure 30. Enteris BioPharma Recent Developments and Future Plans
Figure 31. Dexcom Recent Developments and Future Plans
Figure 32. Senseonics Recent Developments and Future Plans
Figure 33. Medtech Recent Developments and Future Plans
Figure 34. Synertech Recent Developments and Future Plans
Figure 35. Zosano Pharma Recent Developments and Future Plans
Figure 36. Relmada Therapeutics Recent Developments and Future Plans
Figure 37. Eli Lilly and Company Recent Developments and Future Plans
Figure 38. Transdermal Specialties Recent Developments and Future Plans
Figure 39. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Players in 2020
Figure 40. Next Generation Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 41. Global Top 3 Players Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share in 2020
Figure 42. Global Top 10 Players Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share in 2020
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 44. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Type in 2020
Figure 45. Global Next Generation Diabetes Therapy and Drug Delivery Market Share Forecast by Type (2021-2026)
Figure 46. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Application in 2020
Figure 47. Global Next Generation Diabetes Therapy and Drug Delivery Market Share Forecast by Application (2021-2026)
Figure 48. North America Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Type (2016-2026)
Figure 49. North America Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Application (2016-2026)
Figure 50. North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 51. United States Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Canada Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Mexico Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Europe Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Type (2016-2026)
Figure 55. Europe Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Application (2016-2026)
Figure 56. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 57. Germany Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. France Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. United Kingdom Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Russia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Italy Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Type (2016-2026)
Figure 63. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Region (2016-2026)
Figure 65. China Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Japan Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South Korea Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. India Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Australia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South America Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Type (2016-2026)
Figure 72. South America Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Application (2016-2026)
Figure 73. South America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 74. Brazil Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Argentina Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Type (2016-2026)
Figure 77. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Application (2016-2026)
Figure 78. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 79. Turkey Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. UAE Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
Buy
